Citadel Advisors - ARCA BIOPHARMA INC ownership

ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of ARCA BIOPHARMA INC
ValueSharesWeighting
Q3 2023$21,708
-31.6%
10,800
-31.0%
0.00%
Q2 2023$31,751
-61.3%
15,641
-62.0%
0.00%
Q1 2023$82,010
+63.3%
41,211
+93.7%
0.00%
Q4 2022$50,223
-48.2%
21,281
-54.5%
0.00%
Q3 2022$97,000
-58.7%
46,810
-50.3%
0.00%
Q2 2022$235,000
-1.3%
94,133
-8.6%
0.00%
Q1 2022$238,000
+23.3%
102,937
+15.1%
0.00%
Q4 2021$193,000
-14.2%
89,467
+18.0%
0.00%
Q3 2021$225,000
-16.4%
75,807
-1.1%
0.00%
Q2 2021$269,000
+2.7%
76,686
+6.8%
0.00%
Q1 2021$262,000
+482.2%
71,798
+605.8%
0.00%
Q3 2020$45,00010,1720.00%
Other shareholders
ARCA BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
SG3 Management, LLC 100,000$249,0000.03%
Murchinson Ltd. 50,593$126,0000.02%
Marquette Asset Management, LLC 17,318$43,0000.01%
SG3 Management, LLC 22,706$57,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 46,948$117,0000.00%
Tekla Capital Management LLC 32,461$81,0000.00%
BAILARD, INC. 35,000$87,0000.00%
GROUP ONE TRADING, L.P. 131,501$327,0000.00%
TWO SIGMA SECURITIES, LLC 10,238$25,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 882,900$2,198,0000.00%
View complete list of ARCA BIOPHARMA INC shareholders